These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29224828)

  • 1. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
    van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
    Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum, plasma and saliva biomarkers for head and neck cancer.
    Arantes LMRB; De Carvalho AC; Melendez ME; Lopes Carvalho A
    Expert Rev Mol Diagn; 2018 Jan; 18(1):85-112. PubMed ID: 29134827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?
    van Ginkel JH; Huibers MMH; Noorlag R; de Bree R; van Es RJJ; Willems SM
    Pathobiology; 2017; 84(3):115-120. PubMed ID: 27974721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.
    Ipenburg NA; Koole K; Liem KS; van Kempen PM; Koole R; van Diest PJ; van Es RJ; Willems SM
    Target Oncol; 2016 Feb; 11(1):17-27. PubMed ID: 26115874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
    Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
    J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma.
    Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H
    Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and expectations about miRNAs as biomarkers in head and neck squamous cell cancers.
    Galindo Torres BP; García Girón C; Alcaraz Ortega R; Saiz López P; Adiego Leza MI; Grijalba Uche MV
    Am J Otolaryngol; 2023; 44(2):103771. PubMed ID: 36603378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India.
    Kumar M; Srivastava S; Singh SA; Das AK; Das GC; Dhar B; Ghosh SK; Mondal R
    Tumour Biol; 2017 Oct; 39(10):1010428317736643. PubMed ID: 29072129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer.
    Egyud M; Sridhar P; Devaiah A; Yamada E; Saunders S; Ståhlberg A; Filges S; Krzyzanowski PM; Kalatskaya I; Jiao W; Stein LD; Jalisi S; Godfrey TE
    Head Neck; 2019 May; 41(5):1351-1358. PubMed ID: 30554450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
    Ebnoether E; Muller L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
    Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
    Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
    Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
    Kang JW; Eun YG; Lee YC
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.